Caffeic acid phenethyl ester downregulates phospholipase D1 via direct binding and inhibition of NFκB transactivation

Biochemical and Biophysical Research Communications

Volumn 442, Issue 1-2, 2013, Pages 1-7

  Park, Mi Hee ^a   Kang, Dong Woo ^a   Jung, Yunjin ^a   Choi, Kang Yell ^b   Min, Do Sik ^a  

^a Pusan National University   (South Korea)

^b Yonsei University   (South Korea)

Author keywords

Caffeic acid phenethyl ester; Glioma cells; Invasion; Phospholipase D; Proliferation

Indexed keywords

CAFFEIC ACID PHENETHYL ESTER; GELATINASE A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHATIDIC ACID; PHOSPHOLIPASE D1;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; GLIOMA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; RECEPTOR DOWN REGULATION; TRANSACTIVATION;

CAFFEIC ACID PHENETHYL ESTER; GLIOMA CELLS; INVASION; PHOSPHOLIPASE D; PROLIFERATION;

ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CAFFEIC ACIDS; CELL LINE, TUMOR; DOWN-REGULATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; NF-KAPPA B; PHENYLETHYL ALCOHOL; PHOSPHOLIPASE D; PROMOTER REGIONS, GENETIC; PROPOLIS; TRANSCRIPTIONAL ACTIVATION;

EID: 84889682787     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.09.105     Document Type: Article

References (27)

1. F.B. Furnari, T. Fenton, R.M. Bachoo, A. Mukasa, J.M. Stommel, A. Stegh, W.C. Hahn, K.L. Ligon, D.N. Louis, and C. Brennan Malignant astrocytic glioma: genetics, biology, and paths to treatment Genes Dev. 21 21 2007 2683 2710
2. S. Sathornsumetee, D.A. Reardon, A. Desjardins, J.A. Quinn, J.J. Vredenburgh, and J.N. Rich Molecularly targeted therapy for malignant glioma Cancer 10 1 2007 13 24
3. F. Lefranc, J. Brotchi, and R. Kiss Possible future issues in the treatment of glioblastomas: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis J. Clin. Oncol. 23 10 2005 2411 2422
4. T. Demuth, and M.E. Berens Molecular mechanisms of glioma cell migration and invasion J. Neurooncol. 70 2 2004 217 228
5. P.A. Forsyth, H. Wong, T.D. Laing, N.B. Rewcastle, D.G. Morris, H. Muzik, K.J. Leco, R.N. Johnston, P.M. Brasher, and G. Sutherland Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas Br. J. Cancer 79 1999 1828 1835
6. C.J. Weng, and G.C. Yen Chemopreventive effects of dietary phytochemicals against cancer invasion and metastasis: phenolic acids, monophenol, polyphenol, and their derivatives Cancer Treat. Rev. 38 1 2012 76 87
7. H.J. Hwang, H.J. Park, H.J. Chung, H.Y. Min, E.J. Park, J.Y. Hong, and S.K. Lee Inhibitory effects of caffeic acid phenethyl ester on cancer cell metastasis mediated by the down-regulation of matrix metalloproteinase expression in human HT1080 fibrosarcoma cells J. Nutr. Biochem. 17 5 2005 356 362
8. M.J. Weyant, A.M. Carothers, M.E. Bertagnolli, and M.M. Bertagnolli Colon cancer chemopreventive drugs modulate integrin-mediated signaling pathways Clin. Cancer Res. 6 3 2000 949 956
9. C.E. Carrasco-Legleu, L. Márquez-Rosado, S. Fattel-Fazenda, E. Arce-Popoca, J.I. Pérez-Carreón, and S. Villa-Treviño Chemoprotective effect of caffeic acid phenethyl ester on promotion in a medium-term rat hepatocarcinogenesis assay Int. J. Cancer 108 4 2004 488 492
10. M.H. Park, B.H. Ahn, Y.K. Hong, and D.S. Min Overexpression of phospholipase D enhances matrix metalloproteinase-2 expression and glioma cell invasion via protein kinase C and protein kinase A/NF-kappaB/Sp1-mediated signaling pathways Carcinogenesis 30 2 2009 356 365
11. S.M. Hammond, Y.M. Altshuller, T.C. Sung, S.A. Rudge, K. Rose, J. Engebrecht, A.J. Morris, and M.A. Frohman Human ADP-ribosylation factor-activated phosphatidylcholine-specific phospholipase D defines a new and highly conserved gene family J. Biol. Chem. 270 50 1995 29640 29643
12. W.C. Lley, T.C. Sung, R. Roll, J. Jenco, S.M. Hammond, Y. Altshuller, D. Bar-Sagi, A.J. Morris, and M.A. Frohman Phospholipase D2, a distinct phospholipase D isoform with novel regulatory properties that provokes cytoskeletal reorganization Curr. Biol. 7 3 1997 191 201
13. X. Peng, and M.A. Frohman Mammalian phospholipase D physiological and pathological roles Acta Physiol. (Oxf) 204 2 2012 219 226
14. D.W. Kang, M.H. Park, Y.J. Lee, H.S. Kim, T.K. Kwon, W.S. Park, and D.S. Min Phorbol ester up-regulates phospholipase D1 but not phospholipase D2 expression through a PKC/Ras/ERK/NF{kappa}B-dependent pathway and enhances matrix metalloproteinase-9 secretion in colon cancer cells J. Biol. Chem. 283 2008 4094 4104
15. B.H. Ahn, G. Min, Y.S. Bae, Y.S. Bae, and D.S. Min Phospholipase D is activated and phosphorylated by casein kinase-II in human U 87 astroglioma Exp. Mol. Med. 38 2006 55 62
16. D.S. Min, T.K. Kwon, W.S. Park, J.S. Chang, S.K. Park, B.H. Ahn, Z.Y. Ryoo, Y.H. Lee, Y.S. Lee, and D.J. Rhie Neoplastic transformation and tumorigenesis associated with overexpression of phospholipase D isozymes in cultured murine fibroblasts Carcinogenesis 22 2001 1641 1647
17. H. Kim, W. Kim, S. Yum, S. Hong, J.E. Oh, J.W. Lee, M.K. Kwak, E.J. Park, D.H. Na, and Y. Jung Caffeic acid phenethyl ester activation of Nrf2 pathway is enhanced under oxidative state: structural analysis and potential as a pathologically targeted therapeutic agent in treatment of colonic inflammation Free Radic. Biol. Med. 65 2013 552 562
18. D.W. Kang, and D.S. Min Platelet derived growth factor increases phospholipase D1 but not phospholipase D2 expression via NFkappaB signaling pathway and enhances invasion of breast cancer cells Cancer Lett. 294 1 2010 125 133
19. Y. Lee, D.H. Shin, J.H. Kim, S. Hong, D. Choi, Y.J. Kim, M.K. Kwak, and Y. Jung Caffeic acid phenethyl ester-mediated Nrf2 activation and IkappaB kinase inhibition are involved in NFkappaB inhibitory effect: structural analysis for NFkappaB inhibition Eur. J. Pharmacol. 643 1 2010 21 28
20. P. Huang, and M.A. Frohman The potential for phospholipase D as a new therapeutic target Expert Opin. Ther. Targets 11 5 2007 707 716
21. D.W. Kang, K.Y. Choi, and D.S. Min Phospholipase D meets Wnt signaling: a new target for cancer therapy Cancer Res. 71 2 2011 293 297
22. W. Su, Q. Chen, and M.A. Frohman Targeting phospholipase D with small-molecule inhibitors as a potential therapeutic approach for cancer metastasis Future Oncol. 5 9 2009 1477 1486
23. S.A. Scott, P.E. Selvy, J.R. Buck, H.P. Cho, T.L. Criswell, A.L. Thomas, M.D. Armstrong, C.L. Arteaga, C.W. Lindsley, and H.A. Brown Design of isoform-selective phospholipase D inhibitors that modulate cancer cell invasiveness Nat. Chem. Biol. 5 2 2009 108 117
24. M.H. Park, and D.S. Min Quercetin-induced downregulation of phospholipase D1 inhibits proliferation and invasion in U87 glioma cells Biochem. Biophys. Res. Commun. 412 4 2011 710 715
25. D.W. Kang, J.Y. Lee, D.H. Oh, S.Y. Park, T.M. Woo, M.K. Kim, M.H. Park, Y.H. Jang, and D.S. Min Triptolide-induced suppression of phospholipase D expression inhibits proliferation of MDA-MB-231 breast cancer cells Exp. Mol. Med. 41 9 2009 678 685
26. D.W. Kang, G. Min, Y. Park Do, K.W. Hong, and D.S. Min Rebamipide-induced downregulation of phospholipase D inhibits inflammation and proliferation in gastric cancer cells Exp. Mol. Med. 42 8 2010 555 564
27. C. Gialeli, A.D. Theocharis, and N.K. Karamanos Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting FEBS J. 278 1 2001 16 27